# Unilever share price today (Unilever PLC, UL)

> Unilever PLC's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. UL · Consumer Staples · Household & Personal Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ul

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from fewer quarters than usual
- Price: $64.81 (−4.3% in a year)
- P/E: 13.3×, against its own history
- Revenue (Jun 2026): EUR 25.6 B (+0.5% on a year ago)
- Profit (Jun 2026): EUR 3.6 B (−6.1% on a year ago)
- Operating margin: 20.3% (−0.1 points on a year ago)
- ROE: 57%, FY25
- ROIC: 15.8%, against a 5.9% cost of capital: +9.9 points

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. ## What is the Unilever share price today? Unilever PLC's share price was $64.81 at the close on 3 November 2026. It has been stalling near its high for 4 weeks. That is 3.6% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 4 weeks in a row. In the last 52 weeks it traded between $55 and $75, and at that close it sat 49% of the way up from that low. Over the last 10 years the share price moved +21% while the S&P 500 moved +255%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Unilever pay? Unilever PLC declared EUR 0.93 per local share for Jun 2026, and EUR 3.87 over the last four reported quarters. It reports in euros, and one US-listed share can stand for several local shares, so we do not set this against the dollar price or show a yield. ## Which stock lists is Unilever on? Unilever is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Unilever profitable? Unilever PLC earned EUR 3.6 B of net profit in the Jun 2026 quarter, −6.1% on the same quarter a year earlier. Full-year FY25 profit was EUR 10.0 B. Over 4 years profit has grown 10.9% a year on average. That is 14.0% of the quarter's revenue. The same quarter a year earlier earned EUR 3.9 B. For the full year, FY25 profit was EUR 10.0 B (+57.4% on the year before). Why profit moved: revenue changed +0.5% on a year earlier and the margin moved −0.1 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −10.8% and revenue −4.8%. Profit is growing slower than sales: rising costs are taking part of the growth. This company reports in euros, not US dollars, so the money charts are left out here. The figures in the text are in that currency (EUR); nothing is converted. ## How much revenue does Unilever make, and is it growing? Unilever PLC reported EUR 25.6 B of revenue in the Jun 2026 quarter, +0.5% on the same quarter a year earlier. Over 4 years it has grown −0.9% a year on average. The last full year, FY25, came in at EUR 50.5 B. FY25 revenue was EUR 50.5 B, −3.8% on the year before. Recent pace: the last four quarters grew −4.8% on average, against −0.9% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −4.9%, against +4.3% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −4.6%, against +9.2% a year (rolling over). This company reports in euros, not US dollars, so the money charts are left out here. The figures in the text are in that currency (EUR); nothing is converted. ## How much of its sales does Unilever keep? Unilever PLC's operating margin was 20.3% in the Jun 2026 quarter, 0.1 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Over the last four quarters it has moved +3.0 percentage points. Across 5 years it has been between 15.8% and 20.1%. The latest quarter is above every full year in that period. Across 5 years it has been between 15.8% and 20.1%, and FY25's 20.1% is the highest of them. Why the margin moved: operating margin changed +3.0 percentage points on the year while gross margin changed +0.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Unilever's profit turning into cash? Over the last 3 years, 116% of Unilever PLC's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in EUR 8.3 B of operating cash against EUR 10.0 B of profit. After EUR 1.4 B of spending on assets, EUR 6.9 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. This company reports in euros, not US dollars, so the money charts are left out here. The figures in the text are in that currency (EUR); nothing is converted. ## Where does Unilever's cash go? Unilever PLC does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent EUR 4.0 B on assets over the last 3 years. Averaged over those years that is 2.6% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: EUR 4.0 B over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. This company reports in euros, not US dollars, so the money charts are left out here. The figures in the text are in that currency (EUR); nothing is converted. ## What is Unilever's P/E ratio, and how does it compare with its own history? Unilever PLC's P/E is 13.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Unilever business getting better or worse? Unilever PLC's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 42.4%; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: when the lines disagree, each line above matters more than any single label. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Unilever earn on its capital? Unilever PLC earned a ROE of 57% in FY25. That is up from a low of 28% in FY24. Its return on capital used (ROIC) is 9.9 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 19.8% net margin and 0.72× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 19.8% net margin × 0.72× asset turnover × 4.01× leverage (assets divided by equity) ≈ 57.2% on equity. The margin does most of the work; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 15.8% − 5.9% = +9.9 percentage points. The 5.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. ## Does Unilever have too much debt? Unilever PLC has total debt of EUR 32.1 B against shareholder equity of EUR 18.3 B as of Jun 2026, so its debt is 1.75× its equity. Year by year, that ratio went from 1.53 in FY21 to 1.61 in FY25. Keep that borrowing in mind when reading the returns on this page. This company reports in euros, not US dollars, so the money charts are left out here. The figures in the text are in that currency (EUR); nothing is converted. ## What is the Unilever shareholding pattern? We have no ownership or short-position figures for Unilever PLC, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 1.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Unilever from balance-sheet trouble? For Unilever PLC, the Z-score is 3.07. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.07 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Unilever rank in its industry? 50.1 out of 100, rank 20 of 20 in Household & Personal Products, with 47% of the evidence available. It is provisional, so it is ranked below companies with full evidence. Unilever PLC scores 50.1 out of 100 against the 20 companies it is compared with in Household & Personal Products, ranking 20. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 18.1 + 15.3 + 9.1 + 7.6 = 50.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Unilever compared with? Unilever ranks 20 of 20 Household & Personal Products companies on the 4-Factor Sector Score, with 50.1 out of 100. 1. [Kenvue Inc.](https://www.sectoralpha.in/us/stocks/kvue) KVUE · Evidence leans up · 61% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.7/43.75 · Revenue 1.8% · Profit 16.9% · Operating margin change -0.4 points · 83% evidence Capital efficiency 21.1/31.25 · ROCE 14.4% · Operating margin 19.4% · 76% evidence Valuation 15.1/25 · P/E 22.2× · PEG 1.37 · 65% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 27.7 + 21.1 + 15.1 = 63.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 2. [Church & Dwight Co., Inc.](https://www.sectoralpha.in/us/stocks/chd) CHD · turning · Evidence leans up · 81% evidence 61.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.6/35 · Revenue 2.7% · Profit 41.9% · Operating margin change -2.7 points · 83% evidence Capital efficiency 15.8/25 · ROCE 14.6% · Operating margin 18.1% · 76% evidence Valuation 14.3/20 · P/E 30.8× · PEG 0.66 · 65% evidence Relative strength 13.1/20 · Lead over its industry 1.3% · Lead over S&P 500 8.7% · 1 year 25.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 18.6 + 15.8 + 14.3 + 13.1 = 61.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [The Estée Lauder Companies Inc.](https://www.sectoralpha.in/us/stocks/el) EL · leader · Evidence leans up · 64% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 5% · Profit n/a · Operating margin change 2.7 points · 62% evidence Capital efficiency 11.0/25 · ROCE 12.3% · Operating margin 7% · 76% evidence Valuation 11.5/20 · P/E -104.7× · PEG n/a · 15% evidence Relative strength 13.2/20 · Lead over its industry 0% · Lead over S&P 500 6.7% · 1 year 20.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.7 + 11 + 11.5 + 13.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Procter & Gamble Company](https://www.sectoralpha.in/us/stocks/pg) PG · turning · Evidence leans up · 85% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 3.5% · Profit -4.4% · Operating margin change 0.3 points · 95% evidence Capital efficiency 21.2/25 · ROCE 24.6% · Operating margin 27.1% · 76% evidence Valuation 6.7/20 · P/E 21.4× · PEG 2.4 · 65% evidence Relative strength 10.5/20 · Lead over its industry -3.3% · Lead over S&P 500 3.7% · 1 year 10.3% · 100% evidence · 3 of 12 weeks ahead Exact sum: 19.7 + 21.2 + 6.7 + 10.5 = 58.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 5. [Colgate-Palmolive Company](https://www.sectoralpha.in/us/stocks/cl) CL · turning · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.2/35 · Revenue 5.2% · Profit -29.2% · Operating margin change 0.1 points · 83% evidence Capital efficiency 21.1/25 · ROCE 40.8% · Operating margin 21% · 76% evidence Valuation 7.7/20 · P/E 36× · PEG 2.18 · 65% evidence Relative strength 8.1/20 · Lead over its industry -3.6% · Lead over S&P 500 3.4% · 1 year 21.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.2 + 21.1 + 7.7 + 8.1 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Acme United Corporation](https://www.sectoralpha.in/us/stocks/acu) ACU · leader · Evidence leans up · 81% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 9.3% · Profit -9.1% · Operating margin change -0.9 points · 83% evidence Capital efficiency 10.9/25 · ROCE 8.7% · Operating margin 10.9% · 76% evidence Valuation 6.7/20 · P/E 18.5× · PEG 2.5 · 65% evidence Relative strength 19.1/20 · Lead over its industry 28% · Lead over S&P 500 36.8% · 1 year 88.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 16.8 + 10.9 + 6.7 + 19.1 = 53.5 · What this means: Relative strength against the index is 36.8%, and revenue and profit growth are weak. 7. [Interparfums, Inc.](https://www.sectoralpha.in/us/stocks/ipar) IPAR · quiet · Evidence leans up · 81% evidence 52.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 2.9% · Profit 4.4% · Operating margin change -5.4 points · 83% evidence Capital efficiency 17.9/25 · ROCE 21% · Operating margin 12.3% · 76% evidence Valuation 9.7/20 · P/E 21.4× · PEG 1.99 · 65% evidence Relative strength 10.9/20 · Lead over its industry 3% · Lead over S&P 500 10.3% · 1 year 34% · 100% evidence · 5 of 12 weeks ahead Exact sum: 13.9 + 17.9 + 9.7 + 10.9 = 52.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Kimberly-Clark Corporation](https://www.sectoralpha.in/us/stocks/kmb) KMB · basing · Evidence leans up · 81% evidence 50.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue 0.7% · Profit -18.9% · Operating margin change 2.8 points · 83% evidence Capital efficiency 20.6/25 · ROCE 24.6% · Operating margin 19% · 76% evidence Valuation 7.6/20 · P/E 18.6× · PEG 2.38 · 65% evidence Relative strength 5.2/20 · Lead over its industry -10% · Lead over S&P 500 -3.6% · 1 year 0.6% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.1 + 20.6 + 7.6 + 5.2 = 50.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Newell Brands Inc.](https://www.sectoralpha.in/us/stocks/nwl) NWL · losing its lead · Evidence leans up · 64% evidence 50.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue -2% · Profit n/a · Operating margin change 5.2 points · 62% evidence Capital efficiency 8.6/25 · ROCE 7.3% · Operating margin 14.7% · 76% evidence Valuation 11.0/20 · P/E -11.8× · PEG n/a · 15% evidence Relative strength 11.4/20 · Lead over its industry 8.6% · Lead over S&P 500 16% · 1 year 77.6% · 100% evidence · 7 of 12 weeks ahead Exact sum: 19.3 + 8.6 + 11 + 11.4 = 50.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Helen of Troy Limited](https://www.sectoralpha.in/us/stocks/hele) HELE · turning · Evidence leans down · 67% evidence 49.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.8/35 · Revenue 0.3% · Profit n/a · Operating margin change -2.6 points · 71% evidence Capital efficiency 9.4/25 · ROCE 9.8% · Operating margin 0.5% · 76% evidence Valuation 10.7/20 · P/E -7.1× · PEG n/a · 15% evidence Relative strength 14.3/20 · Lead over its industry 13.8% · Lead over S&P 500 22.2% · 1 year 52.3% · 100% evidence · 2 of 12 weeks ahead Exact sum: 14.8 + 9.4 + 10.7 + 14.3 = 49.2 · What this means: Relative strength against the index is 22.2%, and revenue and profit growth are weak. 11. [e.l.f. Beauty, Inc.](https://www.sectoralpha.in/us/stocks/elf) ELF · leader · Evidence leans down · 81% evidence 48.7 out of 100 Growth Capital Valuation Relative
12. [Spectrum Brands Holdings, Inc.](https://www.sectoralpha.in/us/stocks/spb) SPB · quiet · Evidence leans down · 81% evidence 45.1 out of 100 Growth Capital Valuation Relative
13. [Coty Inc.](https://www.sectoralpha.in/us/stocks/coty) COTY · breaking out · Evidence leans down · 64% evidence 44.3 out of 100 Growth Capital Valuation Relative
14. [Edgewell Personal Care Company](https://www.sectoralpha.in/us/stocks/epc) EPC · turning · Evidence leans down · 71% evidence 41.6 out of 100 Growth Capital Valuation Relative
15. [Magnera Corporation](https://www.sectoralpha.in/us/stocks/magn) MAGN · quiet · Evidence leans down · 64% evidence 39.4 out of 100 Growth Capital Valuation Relative
16. [The Clorox Company](https://www.sectoralpha.in/us/stocks/clx) CLX · basing · Evidence leans down · 81% evidence 38.4 out of 100 Growth Capital Valuation Relative
17. [The Honest Company, Inc.](https://www.sectoralpha.in/us/stocks/hnst) HNST · losing its lead · Evidence leans down · 71% evidence 35.0 out of 100 Growth Capital Valuation Relative
18. [Nu Skin Enterprises, Inc.](https://www.sectoralpha.in/us/stocks/nus) NUS · basing · Most evidence points down · 71% evidence 30.6 out of 100 Growth Capital Valuation Relative
19. [Oddity Tech Ltd.](https://www.sectoralpha.in/us/stocks/odd) ODD · breaking out · Most evidence points down · 81% evidence 24.7 out of 100 Growth Capital Valuation Relative
20. Unilever PLC this page UL · turning · Too little evidence to rank firmly · 47% evidence 50.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue n/a · Profit n/a · Operating margin change -0.1 points · 13% evidence Capital efficiency 15.3/25 · ROCE 10.9% · Operating margin 20.3% · 76% evidence Valuation 9.1/20 · P/E 34.1× · PEG n/a · 15% evidence Relative strength 7.6/20 · Lead over its industry -9.1% · Lead over S&P 500 -2.8% · 1 year -6.3% · 100% evidence · 5 of 12 weeks ahead Exact sum: 18.1 + 15.3 + 9.1 + 7.6 = 50.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Household & Personal Products](https://www.sectoralpha.in/us/sectors/household-personal-products), all 20 compared on one page. ## Which companies are close to Unilever in size? Unilever is the 2nd largest of 22 Household & Personal Products companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: The Procter & Gamble Company. Just below it: Colgate-Palmolive Company, The Estée Lauder Companies Inc., Kenvue Inc., Kimberly-Clark Corporation and Church & Dwight Co., Inc. ### Household & Personal Products companies close in size

1. [The Procter & Gamble Company](https://www.sectoralpha.in/us/stocks/pg) $375.6 billion
2. Unilever PLC $140.3 billion
3. [Colgate-Palmolive Company](https://www.sectoralpha.in/us/stocks/cl) $76 billion
4. [The Estée Lauder Companies Inc.](https://www.sectoralpha.in/us/stocks/el) $38.1 billion
5. [Kenvue Inc.](https://www.sectoralpha.in/us/stocks/kvue) $37.1 billion
6. [Kimberly-Clark Corporation](https://www.sectoralpha.in/us/stocks/kmb) $34.7 billion
7. [Church & Dwight Co., Inc.](https://www.sectoralpha.in/us/stocks/chd) $25.8 billion

[All 22 Household & Personal Products companies, largest first](https://www.sectoralpha.in/us/sectors/household-personal-products#all-companies)

### Companies close in size in other industries

1. [Rio Tinto Group](https://www.sectoralpha.in/us/stocks/rio) $143.7 billion · Other Industrial Metals & Mining
2. [Eaton Corporation plc](https://www.sectoralpha.in/us/stocks/etn) $142.2 billion · Specialty Industrial Machinery
3. Unilever PLC $141.6 billion
4. [Chubb Limited](https://www.sectoralpha.in/us/stocks/cb) $141 billion · Insurance - Property & Casualty
5. [Vertex Pharmaceuticals Incorporated](https://www.sectoralpha.in/us/stocks/vrtx) $140.2 billion · Biotechnology

## What else do people ask about Unilever? ### What is Unilever's stock price today? Unilever PLC's stock price is $64.81, −4.3% over the past year. The whole company is worth $140 B on the market. In the last 52 weeks it traded between $55 to $75; today it is 49% of the way up from the low, 3.6% above its 200-day average (as of 3 November 2026). ### What were Unilever's latest quarterly results? Unilever PLC reported revenue of EUR 25.6 B and net profit of EUR 3.6 B for the Jun 2026 quarter. Revenue rose 0.5% and profit fell 6.1% compared with a year earlier. The operating margin was 20.3%, 0.1 percentage points lower than a year earlier (as of 3 November 2026). ### What is Unilever's market cap? Unilever PLC's market capitalisation is $140 B at a stock price of $64.81. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Unilever performing? Unilever PLC's share price has been stalling near its high for 4 weeks. In its latest quarter, revenue rose 0.5% and profit fell 6.1% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 4 weeks running (as of 3 November 2026). ### Will Unilever's stock price go up? This page does not forecast Unilever PLC's stock price. What it shows instead: the stock price is $64.81, and it has been stalling near its high for 4 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Is Unilever's profit real cash? Yes, over the last 3 years, 116% of Unilever PLC's reported profit came in as cash from operations. The latest year was lower at 84%, so the trend is worth watching. In FY25, operating cash was EUR 8.3 B against reported profit of EUR 10.0 B. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Unilever in its business cycle? Unilever PLC's FY25 operating margin was 20.1%, against a 5-year range of 15.8% to 20.1%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 20.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Unilever story? Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Unilever a stock worth studying right now? What the numbers show: Unilever PLC's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.